(Q28236638)

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Contraceptive hormone use and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Hormonal contraception: present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

New progestagens for contraceptive use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Different cardiovascular effects of progestins according to structure and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Study of low-density lipoprotein receptor regulation by oral (steroid) contraceptives: desogestrel, levonorgestrel and ethinyl estradiol in JEG-3 cell line and placental tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effect of dienogest-containing oral contraceptives on lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Hormonal contraception and risk of venous thromboembolism: national follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Metabolic effects of implantable steroid contraceptives for women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Comparative pharmacology of newer progestogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Enhanced hepatic extraction of estrogens used for replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effects of progestogens on haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Comparison of pharmacodynamic properties of various estrogen formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Mechanisms of sex steroids. Future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effect of four oral contraceptives on hemostatic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

The contraceptive vaginal ring (NuvaRing) and hemostasis: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Progestogen-only contraception in women at high risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Insulin resistance, secretion, and metabolism in users of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Oral contraceptives: effects on carbohydrate metabolism, insulin like activity and histology of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Mutual Modification of Glucose-Stimulated Serum Insulin Responses in Female Rhesus Monkeys by Ethinyl Estradiol and Nortestosterone Derivatives1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9182-4

Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys

21 January 2018

1 reference

12 December 2020

Effects of contraceptive estrogen and progestin on the atherogenic potential of plasma LDLs in cynomolgus monkeys

1 reference

12 December 2020

Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile

1 reference

12 December 2020

Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?

1 reference

12 December 2020

The pharmacokinetics and metabolism of ethinyl estradiol and its three sulfates in the baboon

1 reference

12 December 2020

Nonoral routes of estrogen administration

1 reference

12 December 2020

Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol

1 reference

12 December 2020

Hormonal contraception and risk of cardiovascular disease. An international perspective

1 reference

12 December 2020

Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives

1 reference

12 December 2020

Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man

1 reference

12 December 2020

Hormone therapy and recurrence of venous thromboembolism among postmenopausal women

1 reference

12 December 2020

Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor

1 reference

12 December 2020

Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.

1 reference

12 December 2020

Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.

1 reference

12 December 2020

Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study

1 reference

12 December 2020

Influence of a new oral contraceptive with drospirenone on lipid metabolism

1 reference

12 December 2020

Pharmacological profile of progestins

1 reference

12 December 2020

Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers

1 reference

12 December 2020

Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters

1 reference

12 December 2020

A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal

1 reference

12 December 2020

Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study

1 reference

12 December 2020

Effect of oral contraceptives on haemostasis variables.

1 reference

12 December 2020

A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways

1 reference

12 December 2020

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol

1 reference

12 December 2020

Effects of nomegestrol acetate on carbohydrate metabolism.

1 reference

12 December 2020

Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus

1 reference

12 December 2020